I agree hematite the smart move would have been sell @ $2.00 odd and hold the new shares if you were in for a quick profit. Personally I held what I have and will hold this new parcel too.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%